HILLHOUSE INVESTMENT MANAGEMENT LTD. 13D and 13G filings for Legend Biotech Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:40 pm Sale |
2023-12-31 | 13G | Legend Biotech Corporation LEGN |
HILLHOUSE INVESTMENT MANAGEMENT LTD. | 13,052,732 3.600% |
-7,220,502 (-35.62%) |
Filing |
| 2023-02-14 4:12 pm Sale |
2022-12-31 | 13G | Legend Biotech Corporation LEGN |
HILLHOUSE INVESTMENT MANAGEMENT LTD. | 20,273,234 5.900% |
-13,336,616 (-39.68%) |
Filing |
| 2022-02-14 4:11 pm Purchase |
2021-12-31 | 13G | Legend Biotech Corporation LEGN |
HILLHOUSE INVESTMENT MANAGEMENT LTD. | 33,609,850 10.600% |
2,800,000 (+9.09%) |
Filing |
| 2021-07-12 4:15 pm Purchase |
2021-05-31 | 13G | Legend Biotech Corporation LEGN |
HILLHOUSE INVESTMENT MANAGEMENT LTD. | 30,809,850 10.300% |
30,809,850 (New Position) |
Filing |